Neoadjuvant Chemotherapy: A Medical Oncologist's Perspective
Dr. Rita Nanda, assistant professor of medicine, explains the goals of neoadjuvant therapy, response to chemotherapy by breast cancer subsets (HER2, TN, HR+) and endocrine therapy. Dr. Nanda also discusses future trends in neoadjuvant therapy.
Published
April 22, 2016
Created by
Related Presenters
Assistant Professor of Medicine
Rita Nanda, MD, specializes in the treatment of breast cancer. She has particular expertise in the treatment of triple-negative, early onset, hereditary, and locally-advanced breast cancers. She is a strong advocate of using chemotherapy ...